Lilly Buys Psychedelics Maker Atai Beckley for $2.8B
Eli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Understand how zero based budgeting stacks up against traditional monthly methods and which approach best suits your financial goals.
18,282 articlesEli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Two tech names, two very different stories. This guide breaks down Palantir and Microsoft to answer a simple question...
Magic Eden confirms a strategic pivot, winding down Ethereum, Polygon, and Bitcoin NFT marketplaces to double down on...
Learn how mib: jeff chang, president and Vest co-founder built a company focused on practical hedging. This article b...
Amazon unveils a bold plan to expand Leo satellites, targeting 1 Gbps speeds and enterprise deals that could disrupt ...
After an 11% drop, investors wonder if CoreWeave stock can rebound. This article weighs the bull and bear cases, what...
When sandisk stock just popped, traders watched for AI data-center demand and memory-market signals. This article bre...
When the government pours billions into quantum research, a surge in quantum stocks often follows. This guide breaks ...
Investors watching the EV and aerospace worlds know two things: Tesla and SpaceX sit at the frontier of tech. Could t...
Kalshi is challenging Illinois' new 15% tax on sports-related prediction markets. This legal move could reshape how p...
MercadoLibre has faced a harsh year, sliding as investors fret about margins and investments. This guide explains why...
Arm Holdings faces a cooling pullback after a strong rally, offering a potential entry point for long-term investors....